Related references
Note: Only part of the references are listed.Triptolide prevents proliferation and migration of Esophageal Squamous Cell Cancer via MAPK/ERK signaling pathway
Ma Yanchun et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
Tsukasa Shibue et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
The challenge of targeting cancer stem cells to halt metastasis
Alice Agliano et al.
SEMINARS IN CANCER BIOLOGY (2017)
MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer
Aimin Yang et al.
CANCER RESEARCH (2017)
Diverse Targets of β-Catenin during the Epithelial-Mesenchymal Transition Define Cancer Stem Cells and Predict Disease Relapse
Yi-Wen Chang et al.
CANCER RESEARCH (2015)
Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases
Feifeng Jing et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Triptolide abrogates growth of colon cancer and induces cell cycle arrest by inhibiting transcriptional activation of E2F
Amanda R. Oliveira et al.
LABORATORY INVESTIGATION (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Enhanced G2/M Arrest, Caspase Related Apoptosis and Reduced E-Cadherin Dependent Intercellular Adhesion by Trabectedin in Prostate Cancer Stem Cells
Eda Acikgoz et al.
PLOS ONE (2015)
Triptolide reverses hypoxia- induced epithelial- mesenchymal transition and stem- like features in pancreatic cancer by NF- jB downregulation
Li Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Induced growth inhibition, cell cycle arrest and apoptosis in CD133+/CD44+ prostate cancer stem cells by flavopiridol
Burak Cem Soner et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2014)
Molecular mechanisms of epithelial-mesenchymal transition
Samy Lamouille et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Triptolide-induced in vitro and in vivo cytotoxicity in human breast cancer stem cells and primary breast cancer cells
Junjie Li et al.
ONCOLOGY REPORTS (2014)
Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
Sara Haggblad Sahlberg et al.
PLOS ONE (2014)
Maintenance of the stemness in CD44+ HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression
Sy-Yeuan Ju et al.
STEM CELL RESEARCH (2014)
Expression profiling of stem cell signaling alters with spheroid formation in CD133high/CD44high prostate cancer stem cells
Gulperi Oktem et al.
ONCOLOGY LETTERS (2014)
The Role of Snail in EMT and Tumorigenesis
Yifan Wang et al.
CURRENT CANCER DRUG TARGETS (2013)
Co-expression of CD133+/CD44+ in human colon cancer and liver metastasis
Antonia Bellizzi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Triptolide inhibits proliferation and invasion of malignant glioma cells
Haipeng Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer
Chunxia Wang et al.
ONCOLOGY REPORTS (2012)
Triptolide inhibits colon-rectal cancer cells proliferation by induction of G1 phase arrest through upregulation of p21
Juanjuan Liu et al.
PHYTOMEDICINE (2012)
Triptolide Inhibits the Proliferation of Prostate Cancer Cells and Down-Regulates SUMO-Specific Protease 1 Expression
Weiwei Huang et al.
PLOS ONE (2012)
The Intestinal Stem Cell Signature Identifies Colorectal Cancer Stem Cells and Predicts Disease Relapse
Anna Merlos-Suarez et al.
CELL STEM CELL (2011)
Highly enriched CD133+CD44+ stem-like cells with CD133+CD44high metastatic subset in HCT116 colon cancer cells
Ke-li Chen et al.
CLINICAL & EXPERIMENTAL METASTASIS (2011)
Triptolide Inhibits Proliferation and Migration of Colon Cancer Cells by Inhibition of Cell Cycle Regulators and Cytokine Receptors
Sara M. Johnson et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Colorectal Cancer Stem Cells: Biology and Therapeutic Implications
Brian J. Wilson et al.
CURRENT COLORECTAL CANCER REPORTS (2011)
A Subpopulation of CD26+ Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer
Roberta Pang et al.
CELL STEM CELL (2010)
Role of Hsp-70 in Triptolide-Mediated Cell Death of Neuroblastoma
Mara B. Antonoff et al.
JOURNAL OF SURGICAL RESEARCH (2010)
A Comprehensive Panel of Three-Dimensional Models for Studies of Prostate Cancer Growth, Invasion and Drug Responses
Ville Harma et al.
PLOS ONE (2010)
Triptolide downregulates Rac1 and the JAK/STAT3 pathway and inhibits colitis-related colon cancer progression
Zhipeng Wang et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Colon cancer stem cells: implications for prevention and therapy
Emina H. Huang et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Phenotypic characterization of human colorectal cancer stem cells
Piero Dalerba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Functional p53 is required for triptolide-induced apoptosis and AP-1 and nuclear factor-κB activation in gastric cancer cells
XH Jiang et al.
ONCOGENE (2001)
Triptolide, a novel immunosuppressive and anti-inflammatory agent purified from a Chinese herb Tripterygium Wilfordii Hook F
BJ Chen
LEUKEMIA & LYMPHOMA (2001)
Share Paper
